Health

Far from being a cure-all, telemedicine brings a whole new set of pros and cons. The barriers are not insignificant. However, a review of telemedicine adoption in the U.S. and beyond provides a good incentive to press forward.

The push for COVID-19 treatments has stoked the fires on big questions about the US pharmaceutical industry, including drug pricing and conflicting data on drug effectiveness. Here's my unvarnished take.

Can we draw algorithmic lessons from our immune response? How do leaders cope with anxiety? Does treating anxiety as an algorithm help us to shift behaviors? I explored these questions with startup executive Adam Goldstein.

Johnson & Johnson recently announced its Heartline Study app, which utilizes Apple Watches and iPhones, with the expected fanfare. But is this really an advancement in wearables? And, based on the official guidelines of clinical trials, does it qualify as a study?